Related Experiment Video
Updated: Jul 23, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
Pearls & Oy-sters: ATX-FGF14 Mimicking Autoimmune Pathology.
Yoji Hoshina1, Melissa A Wright2, Judith E A Warner2
1From the Department of Neurology (Y.H., M.A.W., J.E.A.W., S.M.P., E.S., S.L.C.), Department of Ophthalmology and Visual Sciences (J.E.A.W.), Department of Radiology (T.R., K.L.S.), University of Utah; and George E. Wahlen Veterans Affairs Medical Center (S.L.C.), Salt Lake City, UT. yojihoshina0106@gmail.com.
Autosomal dominant spinocerebellar ataxia 27 (ATX-FGF14) diagnosis can be delayed due to variable symptoms. Detailed family history and genetic testing are crucial for accurate identification, especially when differentiating from autoimmune conditions.
Area of Science:
- Neurogenetics
- Autosomal dominant disorders
- Genetic neurology
Background:
- Autosomal dominant spinocerebellar ataxia 27 (ATX-FGF14) is caused by pathogenic variants in the fibroblast growth factor 14 (FGF14) gene.
- Variable phenotypic expression often complicates diagnosis, particularly in patients lacking a known family history.
Observation:
- Two cases of ATX-FGF14 within a single family presented with episodic neurological symptoms, initially raising suspicion for autoimmune etiologies.
- Both patients exhibited coexistent systemic autoimmunity and lacked cerebellar or brainstem volume loss, further complicating initial diagnostic assessments.
- Initial evaluations revealed limited family history, underscoring the challenge in early diagnosis without comprehensive genetic and familial information.
Findings:
- Genetic testing confirmed a pathogenic structural variant in the FGF14 gene in both affected family members, establishing the diagnosis of ATX-FGF14.
- The study identified a pathogenic structural variant in the FGF14 gene, confirming ATX-FGF14 in both patients.
Implications:
- Highlights the critical importance of obtaining detailed interval family histories during patient follow-ups for undiagnosed adult neurological conditions.
- Emphasizes the need for objective analysis of immunotherapy trials to prevent unnecessary treatments when diagnosing neurogenetic disorders.
- Underscores the necessity of genetic testing for accurate diagnosis of ATX-FGF14, especially when clinical presentations mimic autoimmune neurological diseases.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
TGF - β Signaling Pathway

